Medications

Merck pays $830 M to settle class-action case over Vioxx

The drugmaker Merck is paying $830 million to resolve a federal class-action lawsuit involving shareholders and the painkiller Vioxx, which was pulled from the market years ago over safety concerns.

HIV & AIDS

AIDS research team in US loses $1.38M grant (Update)

An AIDS research team at Iowa State University will not get the final $1.38 million payment of a National Institutes of Health five-year grant after a team member admitted last year to faking research results, the NIH said ...

Medications

Drug manufacturer agrees to $500 million penalty (Update)

A subsidiary of India's largest pharmaceutical company has agreed to pay a record $500 million in fines and penalties for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown ...

page 2 from 2